NORTHWEST BIOTHERAPEUTICS INC Deferred Tax Assets, Gross
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Deferred Tax Assets, Gross of $284.62 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Gross $284.62M.
- 2024-12-31: Deferred Tax Assets, Gross $281.22M.
- 2023-12-31: Deferred Tax Assets, Gross $261.44M.
- 2022-12-31: Deferred Tax Assets, Gross $247.68M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $284.62M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $281.22M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $261.44M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $247.68M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $235.22M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $226.88M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $207.69M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $200.68M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $178.66M 10-K · filed 2019-04-02 | |
| 2016-12-31 | $236.12M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $218.35M 10-K · filed 2017-04-17 | |
| 2014-12-31 | $170.10M 10-K · filed 2016-03-16 | |
| 2013-12-31 | $112.20M 10-K · filed 2015-03-17 | $112.20K 10-K · filed 2014-04-01 |
| 2012-12-31 | $87.62K 10-K · filed 2014-04-01 | $87.62M 10-K · filed 2013-04-08 |
| 2011-12-31 | $51.48M 10-K · filed 2013-04-08 |